NACE Allergy BioRepository
The NACE Allergy BioRepository (ALBI): powering prevention, diagnosis and management of allergic disease through large-scale discovery research
Many Australians living with allergies will have their diagnosis, management and outcomes tracked at a national level for the first time to help address the growing allergy epidemic.
Australia is considered the allergy capital of the world, with allergic disease impacting more than five million people. Research shows:
- One in four people report a drug allergy
- One in 10 infants are diagnosed with food allergy
- Each year, 12 Australians die from bee or wasp sting
- One in four people have allergic rhinitis (hay fever).
While Australia is a global leader in allergy research, information and datasets are unstandardarised fragmented making it challenging for experts to consolidate knowledge and facilitate effective research outcomes. There is a pressing need for coordinated national approaches to bridge knowledge gaps and improve prevention, diagnosis and treatment outcomes.
ALBI overview
To address this lack of a national-level, combined allergy information platform, the NACE is developing an Allergy BioRepository (ALBI). Using cutting-edge digital health technology, ALBI will securely consolidate and integrate data and records of samples from NACE drug, food, insect, and respiratory allergy studies. Over time, it will also pool information from other NACE endorsed studies.
The ALBI information platform will be an innovative, safe and secure system to integrate, manage and storage allergy data in ways that make it visible and accessible, giving researchers the opportunity to harness the power of big data analysis to accelerate their research.
The NACE hopes ALBI will help researchers answer many important questions around:
- How to better prevent allergies
- Ways to improve diagnosing allergies in children and adults
- Opportunities to advance individualised healthcare for people living with this chronic disease.
By gathering information in one location, experts will have a better overall picture of allergies in this country, which will benefit healthcare professionals, allergy patients and the wider community.
NACE Investigators
- Professor Janet Davies, Co-chief Principal Investigator, NACE BioRepository and Discovery Pillar Lead and Respiratory Allergy Stream Co-chair, Head of Allergy Research, Queensland University of Technology
- Professor Kirsten Perrett, Co-chief Principal Investigator, NACE Director and Transforming Allergy Care Pillar Lead
Collaborators
In proud partnership with
